Australian medical robotics company Vexev has announced it has raised US6millioninnewfundingtoacceleratethepathtoUSFoodandDrugAdministration(FDA)510(k)clearanceandUScommercialisationofVxWave,itsrobotictomographicultrasoundplatform,designedtoimproveaccesstostandardisedvascularimaging.Vexev’stotalfundingtodateexceedsUS6 million in new funding to accelerate the path to US Food and Drug Administration (FDA) 510(k) clearance and US commercialisation of VxWave, its robotic tomographic ultrasound platform, designed to improve access to standardised vascular imaging. Vexev’s total funding to date exceeds US19 million. VxWave […] The post Vexev secures funding to advance US commercialisation of VxWave appeared first on Cardiovascular News .